Correlation Between RenovoRx and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Virax Biolabs Group, you can compare the effects of market volatilities on RenovoRx and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Virax Biolabs.
Diversification Opportunities for RenovoRx and Virax Biolabs
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between RenovoRx and Virax is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of RenovoRx i.e., RenovoRx and Virax Biolabs go up and down completely randomly.
Pair Corralation between RenovoRx and Virax Biolabs
Given the investment horizon of 90 days RenovoRx is expected to generate 0.54 times more return on investment than Virax Biolabs. However, RenovoRx is 1.85 times less risky than Virax Biolabs. It trades about 0.29 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about 0.0 per unit of risk. If you would invest 98.00 in RenovoRx on August 28, 2024 and sell it today you would earn a total of 23.00 from holding RenovoRx or generate 23.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
RenovoRx vs. Virax Biolabs Group
Performance |
| Timeline |
| RenovoRx |
| Virax Biolabs Group |
RenovoRx and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Virax Biolabs
The main advantage of trading using opposite RenovoRx and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| RenovoRx vs. Eliem Therapeutics | RenovoRx vs. HCW Biologics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals |
| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |